Associations Between Anxiety, Depression, and the Metabolic Syndrome

Biological Psychiatry

Volumn 62, Issue 11, 2007, Pages 1251-1257

  Skilton, Michael R ^a   Moulin, Philippe ^b,c   Terra, Jean Louis ^a   Bonnet, Fabrice ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

Anxiety; cardiovascular disease; depression; insulin resistance; metabolic syndrome; obesity

Indexed keywords

ADULT; AGED; ANXIETY; ANXIETY DISORDER; ARTICLE; BECK DEPRESSION INVENTORY; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PATIENT ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; CARDIOVASCULAR DISEASES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 35848939197     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2007.01.012     Document Type: Article

References (33)

1. Everson-Rose S.A., Meyer P.M., Powell L.H., Pandey D., Torrens J.I., Kravitz H.M., et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 27 (2004) 2856-2862
2. Timonen M., Laakso M., Jokelainen J., Rajala U., Meyer-Rochow V.B., and Keinanen-Kiukaanniemi S. Insulin resistance and depression: Cross sectional study. BMJ 330 (2005) 17-18
3. Adriaanse M.C., Dekker J.M., Nijpels G., Heine R.J., Snoek F.J., and Pouwer F. Associations between depressive symptoms and insulin resistance: The Hoorn Study. Diabetologia 49 (2006) 2874-2877
4. Raikkonen K., Matthews K.A., and Kuller L.H. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: Antecedent or consequence?. Metabolism 51 (2002) 1573-1577
5. Herva A., Rasanen P., Miettunen J., Timonen M., Laksy K., Veijola J., et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med 68 (2006) 213-216
6. Kinder L.S., Carnethon M.R., Palaniappan L.P., King A.C., and Fortmann S.P. Depression and the metabolic syndrome in young adults: Findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 66 (2004) 316-322
7. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 (1983) 361-370
8. Bjelland I., Dahl A.A., Haug T.T., and Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52 (2002) 69-77
9. Lepine J.P., Godchau M., and Brun P. Anxiety and depression in inpatients. Lancet 2 (1985) 1425-1426
10. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
11. Bonnet F., Irving K., Terra J.L., Nony P., Berthezene F., and Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis 178 (2005) 339-344
12. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., and Pyorala K. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140 (1998) 199-270
13. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA Dietary Guidelines: Revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102 (2000) 2284-2299
14. Altman D.G., and Bland J.M. Interaction revisited: The difference between two estimates. BMJ 326 (2003) 219
15. McCaffery J.M., Niaura R., Todaro J.F., Swan G.E., and Carmelli D. Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom Med 65 (2003) 490-497
16. Berkowitz R.I., and Fabricatore A.N. Obesity, psychiatric status, and psychiatric medications. Psychiatr Clin North Am 28 (2005) 39-54 vii-viii
17. Kawachi I., Sparrow D., Vokonas P.S., and Weiss S.T. Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study. Circulation 90 (1994) 2225-2229
18. Paterniti S., Alperovitch A., Ducimetiere P., Dealberto M.J., Lepine J.P., and Bisserbe J.C. Anxiety but not depression is associated with elevated blood pressure in a community group of French elderly. Psychosom Med 61 (1999) 77-83
19. Albert C.M., Chae C.U., Rexrode K.M., Manson J.E., and Kawachi I. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 111 (2005) 480-487
20. O'Malley P.G., Jones D.L., Feuerstein I.M., and Taylor A.J. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med 343 (2000) 1298-1304
21. Lawlor D.A., Smith G.D., and Ebrahim S. Association of insulin resistance with depression: Cross sectional findings from the British Women's Heart and Health Study. BMJ 327 (2003) 1383-1384
22. Lawlor D.A., Ben-Shlomo Y., Ebrahim S., Davey Smith G., Stansfeld S.A., Yarnell J.W., and Gallacher J.E. Insulin resistance and depressive symptoms in middle aged men: Findings from the Caerphilly prospective cohort study. BMJ 330 (2005) 705-706
23. Piche M.E., Lemieux S., Perusse L., and Weisnagel S.J. High normal 2-hour plasma glucose is associated with insulin sensitivity and secretion that may predispose to type 2 diabetes. Diabetologia 48 (2005) 732-740
24. Mielke J.G., Taghibiglou C., Liu L., Zhang Y., Jia Z., Adeli K., and Wang Y.T. A biochemical and functional characterization of diet-induced brain insulin resistance. J Neurochem 93 (2005) 1568-1578
25. Brunner E.J., Hemingway H., Walker B.R., Page M., Clarke P., Juneja M., et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: Nested case-control study. Circulation 106 (2002) 2659-2665
26. Grassi G., and Seravalle G. Autonomic imbalance and metabolic syndrome: Unravelling interactions, mechanisms and outcomes. J Hypertens 24 (2006) 47-49
27. Kim C.K., McGorray S.P., Bartholomew B.A., Marsh M., Dicken T., Wassertheil-Smoller S., et al. Depressive symptoms and heart rate variability in postmenopausal women. Arch Intern Med 165 (2005) 1239-1244
28. Bench C.J., Friston K.J., Brown R.G., Scott L.C., Frackowiak R.S., and Dolan R.J. The anatomy of melancholia-focal abnormalities of cerebral blood flow in major depression. Psychol Med 22 (1992) 607-615
29. Kobayashi K. Adipokines: Therapeutic targets for metabolic syndrome. Curr Drug Targets 6 (2005) 525-529
30. Bjorntorp P., and Rosmond R. The metabolic syndrome-a neuroendocrine disorder?. Br J Nutr 83 suppl 1 (2000) S49-S57
31. Hill M.N., and Gorzalka B.B. Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?. Behav Pharmacol 16 (2005) 333-352
32. Frasure-Smith N., Lesperance F., and Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 91 (1995) 999-1005
33. Blumenthal J.A., Lett H.S., Babyak M.A., White W., Smith P.K., Mark D.B., et al. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362 (2003) 604-609